Antony Koblish

Co-founder, President
& Chief Executive Officer

Antony Koblish is a medical device entrepreneur with 25 years of experience in health care. Prior to founding TELA Bio, Mr. Koblish was President and Chief Executive Officer of Orthovita, Inc., a publicly traded orthobiologics and biosurgery medical device company. During his tenure as Chief Executive Officer of Orthovita from 2002 to 2011, Mr. Koblish created significant company value, growing valuation from $30M to a $316M exit sale to Stryker Corporation in 2011. He is a skilled leader with a proven track record in driving sales growth, building a robust product pipeline, establishing world-class commercial operations, and instilling clinical and manufacturing quality.

Mr. Koblish is also a co-founder and currently serves as Chairman of the Board of Onkos Surgical, Inc., a surgical oncology company, and is an operating partner with 1315 Capital, a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and health care services companies. Mr. Koblish earned a Master of Science in Engineering degree in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania and holds a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.